Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | CLK1 | P49759 | 2/20 | 0.43 |
| ▸ | CLK2 | P49760 | 2/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.43 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL709817 | 0.88 | CTSK (0.43) | LMNAMAPTNOS1CTSKKMT2A | |
| SCHEMBL710351 | 0.87 | CYP2C19 (0.46) | CTSKCYP19A1MEN1KMT2ATSHR | |
| SCHEMBL10972910 | 0.76 | NPC1 (0.51) | MAPTDYRK1ANPC1MEN1KMT2A | |
| SCHEMBL708351 | 0.75 | DYRK1A (0.48) | CLK1CLK2DYRK1ACLK4DYRK1B | |
| SCHEMBL13884017 | 0.74 | LTA4H (0.65) | MAPTCYP19A1NPC1MEN1KMT2A | |
| SCHEMBL1106643 | 0.74 | LTA4H (0.50) | MAPTCYP19A1NPC1KMT2ASIGMAR1 | |
| SCHEMBL12677664 | 0.74 | CA4 (0.52) | LMNAMAPTNPC1KMT2AALDH1A1 | |
| SCHEMBL6139896 | 0.74 | CA4 (0.52) | LMNAMAPTNPC1KMT2AALDH1A1 | |
| SCHEMBL10057799 | 0.74 | CA4 (0.52) | LMNAMAPTNPC1KMT2AALDH1A1 | |
| SCHEMBL131837 | 0.74 | CA4 (0.52) | LMNAMAPTNPC1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124762-B2 | Diphenyl amine derivatives having luminescence property | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2012-02-28 | — | — | US | disclosed |
| US-8124762-B2 | Diphenyl amine derivatives having luminescence property | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2012-02-28 | — | — | US | disclosed |
| US-8124762-B2 | Diphenyl amine derivatives having luminescence property | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2012-02-28 | — | — | US | disclosed |
| US-20100063281-A1 | DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2010-03-11 | — | — | US | disclosed |
| US-20100063281-A1 | DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2010-03-11 | — | — | US | disclosed |
| US-20100063281-A1 | DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY | KOREA INSTITUTE OF SCIENCE & TECHNOLOGY (KR) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063281-A1 | DIPHENYL AMINE DERIVATIVES HAVING LUMINESCENCE PROPERTY | TYR, PNMT, DDC | LMNA 2277/4885MAPT 137/4885NOS1 1153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.